Literature DB >> 26510851

Dose-response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial.

Kathryn H Schmitz1, Nancy I Williams2, Despina Kontos3, Susan Domchek3, Knashawn H Morales3, Wei-Ting Hwang3, Lorita L Grant3, Laura DiGiovanni3, Domenick Salvatore3, Desire' Fenderson3, Mitchell Schnall3, Mary Lou Galantino3, Jill Stopfer3, Mindy S Kurzer4, Shandong Wu5, Jessica Adelman3, Justin C Brown3, Jerene Good3.   

Abstract

UNLABELLED: Medical and surgical interventions for elevated breast cancer risk (e.g., BRCA1/2 mutation, family history) focus on reducing estrogen exposure. Women at elevated risk may be interested in less aggressive approaches to risk reduction. For example, exercise might reduce estrogen, yet has fewer serious side effects and less negative impact than surgery or hormonal medications. Randomized controlled trial. Increased risk defined by risk prediction models or BRCA mutation status. Eligibility: Age 18-50, eumenorrheic, non-smokers, and body mass index (BMI) between 21 and 50 kg/m(2). 139 were randomized. Treadmill exercise: 150 or 300 min/week, five menstrual cycles. Control group maintained exercise <75 min/week. PRIMARY OUTCOME: Area under curve (AUC) for urinary estrogen. Secondary measures: urinary progesterone, quantitative digitized breast dynamic contrast-enhanced magnetic resonance imaging background parenchymal enhancement. Mean age 34 years, mean BMI 26.8 kg/m(2). A linear dose-response relationship was observed such that every 100 min of exercise is associated with 3.6 % lower follicular phase estrogen AUC (linear trend test, p = 0.03). No changes in luteal phase estrogen or progesterone levels. There was also a dose-response effect noted: for every 100 min of exercise, there was a 9.7 % decrease in background parenchymal enhancement as measured by imaging (linear trend test, p = 0.009). Linear dose-response effect observed to reduce follicular phase estrogen exposure measured via urine and hormone sensitive breast tissue as measured by imaging. Future research should explore maintenance of effects and extent to which findings are repeatable in lower risk women. Given the high benefit to risk ratio, clinicians can inform young women at increased risk that exercise may blunt estrogen exposure while considering whether to try other preventive therapies.

Entities:  

Keywords:  Breast MRI; Breast cancer; Clinical trial; Estrogens; Exercise

Mesh:

Substances:

Year:  2015        PMID: 26510851      PMCID: PMC6196733          DOI: 10.1007/s10549-015-3604-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  39 in total

1.  Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay.

Authors:  C J Munro; G H Stabenfeldt; J R Cragun; L A Addiego; J W Overstreet; B L Lasley
Journal:  Clin Chem       Date:  1991-06       Impact factor: 8.327

2.  Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women.

Authors:  Charles E Matthews; Renee T Fortner; Xia Xu; Susan E Hankinson; A Heather Eliassen; Regina G Ziegler
Journal:  J Clin Endocrinol Metab       Date:  2012-08-01       Impact factor: 5.958

3.  Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Rudolf Kaaks; Franco Berrino; Timothy Key; Sabina Rinaldi; Laure Dossus; Carine Biessy; Giorgio Secreto; Pilar Amiano; Sheila Bingham; Heiner Boeing; H Bas Bueno de Mesquita; Jenny Chang-Claude; Françoise Clavel-Chapelon; Agnès Fournier; Carla H van Gils; Carlos A Gonzalez; Aurelio Barricarte Gurrea; Elena Critselis; Kay Tee Khaw; Vittorio Krogh; Petra H Lahmann; Gabriele Nagel; Anja Olsen; N Charlotte Onland-Moret; Kim Overvad; Domenico Palli; Salvatore Panico; Petra Peeters; J Ramón Quirós; Andrew Roddam; Anne Thiebaut; Anne Tjønneland; Ma Dolores Chirlaque; Antonia Trichopoulou; Dimitrios Trichopoulos; Rosario Tumino; Paolo Vineis; Teresa Norat; Pietro Ferrari; Nadia Slimani; Elio Riboli
Journal:  J Natl Cancer Inst       Date:  2005-05-18       Impact factor: 13.506

4.  Women In Steady Exercise Research (WISER) Sister: study design and methods.

Authors:  Kathryn H Schmitz; Nancy I Williams; Despina Kontos; Mindy S Kurzer; Mitchell Schnall; Susan Domchek; Jill Stopfer; Mary Lou Galantino; Wei-Ting Hwang; Knashawn Morales; Shandong Wu; Laura DiGiovanni; Domenick Salvatore; Desire' Fenderson; Jerene Good; Kathleen Sturgeon; Lorita Grant; Cathy J Bryan; Jess Adelman
Journal:  Contemp Clin Trials       Date:  2015-01-03       Impact factor: 2.226

5.  Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Authors:  Anne Uyei; Susan K Peterson; Julie Erlichman; Kristine Broglio; Sandra Yekell; Kathkeen Schmeler; Karen Lu; Funda Meric-Bernstam; Chris Amos; Louise Strong; Banu Arun
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

6.  Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy.

Authors:  Michael J DeLeo; Susan M Domchek; Despina Kontos; Emily Conant; Jinbo Chen; Susan Weinstein
Journal:  AJR Am J Roentgenol       Date:  2015-03       Impact factor: 3.959

Review 7.  Progesterone involvement in breast development and tumorigenesis--as revealed by progesterone receptor "knockout" and "knockin" mouse models.

Authors:  Preeti M Ismail; Paula Amato; Selma M Soyal; Francesco J DeMayo; Orla M Conneely; Bert W O'Malley; John P Lydon
Journal:  Steroids       Date:  2003-11       Impact factor: 2.668

8.  The Cancer Genetics Network: recruitment results and pilot studies.

Authors:  Hoda Anton-Culver; Argyrios Ziogas; Deborah Bowen; Dianne Finkelstein; Constance Griffin; James Hanson; Claudine Isaacs; Carol Kasten-Sportes; Geraldine Mineau; Prakash Nadkarni; Barbara Rimer; Joellen Schildkraut; Louise Strong; Barbara Weber; Deborah Winn; Robert Hiatt; Susan Nayfield
Journal:  Community Genet       Date:  2003

9.  The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue.

Authors:  E R Price; J D Brooks; E J Watson; S B Brennan; E A Comen; E A Morris
Journal:  Eur Radiol       Date:  2013-08-28       Impact factor: 5.315

Review 10.  Local approaches to hereditary breast cancer.

Authors:  B T Cooper; J O Murphy; V Sacchini; S C Formenti
Journal:  Ann Oncol       Date:  2013-11       Impact factor: 32.976

View more
  18 in total

1.  Dose-dependent effect of aerobic exercise on inflammatory biomarkers in a randomized controlled trial of women at high risk of breast cancer.

Authors:  Jeremy S Haley; Elizabeth A Hibler; Shouhao Zhou; Kathryn H Schmitz; Kathleen M Sturgeon
Journal:  Cancer       Date:  2019-09-30       Impact factor: 6.860

2.  Sex Hormones in Women With Elevated Breast Cancer Risk Undergoing Weight Loss.

Authors:  Sophia A Stone; Claire J Han; Taurence Senn; Larissa A Korde; Kristen Allott; Scott Reding; Dale Whittington; Kerryn W Reding
Journal:  West J Nurs Res       Date:  2019-01-07       Impact factor: 1.967

3.  The dose-response effects of aerobic exercise on musculoskeletal injury: a post hoc analysis of a randomized trial.

Authors:  Justin C Brown; Kathryn H Schmitz
Journal:  Res Sports Med       Date:  2017-04-06       Impact factor: 4.674

Review 4.  HSP70 as a biomarker of the thin threshold between benefit and injury due to physical exercise when exposed to air pollution.

Authors:  Lílian Corrêa Costa-Beber; Thiago Gomes Heck; Pauline Brendler Goettems Fiorin; Mirna Stela Ludwig
Journal:  Cell Stress Chaperones       Date:  2021-10-22       Impact factor: 3.667

5.  Association of Inflammatory Diets with Inflammatory Biomarkers in Women at High Genetic Risk for Breast Cancer.

Authors:  Amanda L Boyer; Andrea Y Arikawa; Kathryn H Schmitz; Kathleen M Sturgeon
Journal:  Nutr Cancer       Date:  2021-10-06       Impact factor: 2.900

Review 6.  Why exercise has a crucial role in cancer prevention, risk reduction and improved outcomes.

Authors:  Robert Thomas; Stacey A Kenfield; Yuuki Yanagisawa; Robert U Newton
Journal:  Br Med Bull       Date:  2021-09-10       Impact factor: 5.841

Review 7.  Progestins and the Risk of Breast Cancer.

Authors:  G Mastorakos; G Iatrakis; S Zervoudis; S Syropoulou
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 1.104

8.  Physical activity barriers and resources among black women with a history of breast and endometrial cancer: a systematic review.

Authors:  Natasha R Burse; Nishat Bhuiyan; Scherezade K Mama; Kathryn H Schmitz
Journal:  J Cancer Surviv       Date:  2020-04-02       Impact factor: 4.442

9.  A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.

Authors:  Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2016-03-10       Impact factor: 2.226

10.  The Dose-Response Effects of Aerobic Exercise on Body Composition and Breast Tissue among Women at High Risk for Breast Cancer: A Randomized Trial.

Authors:  Justin C Brown; Despina Kontos; Mitchell D Schnall; Shandong Wu; Kathryn H Schmitz
Journal:  Cancer Prev Res (Phila)       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.